Literature DB >> 1592778

Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings.

K D Gadow1, E E Nolan, J Sverd.   

Abstract

In this study, 11 prepubertal hyperactive boys with tic disorder received placebo and three doses of methylphenidate (0.1, 0.3, and 0.5 mg/kg) for 2 weeks each, under double-blind conditions. Each boy was observed for approximately 20 hours in the school setting (classroom seatwork activities, lunchroom, and playground). Results showed that methylphenidate effectively suppressed hyperactive/disruptive behaviors in the classroom and physical aggression in the lunchroom and on the playground. Methylphenidate also reduced the occurrence of vocal tics in the classroom and the lunchroom. None of the motor tic measures revealed drug effects, but the lowest mean rate of motor tics occurred on the 0.3 mg/kg dose. On an operationally defined minimal effective dose, only one boy experienced motor tic exacerbation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592778     DOI: 10.1097/00004583-199205000-00012

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  16 in total

Review 1.  Non-stimulant treatments for ADHD.

Authors:  J Biederman; T Spencer
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

2.  Non-stimulant treatment for attention deficit hyperactivity disorder.

Authors:  Kumar Budur; Maju Mathews; Babatunde Adetunji; Manu Mathews; Jamal Mahmud
Journal:  Psychiatry (Edgmont)       Date:  2005-07

3.  Does oligoantigenic diet influence hyperactive/conduct-disordered children--a controlled trial.

Authors:  M H Schmidt; P Möcks; B Lay; H G Eisert; R Fojkar; D Fritz-Sigmund; A Marcus; B Musaeus
Journal:  Eur Child Adolesc Psychiatry       Date:  1997-06       Impact factor: 4.785

Review 4.  Gilles de la Tourette syndrome: symptomatic treatment based on evidence.

Authors:  M M Robertson; J S Stern
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

Review 5.  Pharmacological treatment of psychiatric disorders in children and adolescents: focus on guidelines for the primary care practitioner.

Authors:  N J Carrey; D M Wiggins; R P Milin
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

6.  Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.

Authors:  Michael H Bloch; Kaitlyn E Panza; Angeli Landeros-Weisenberger; James F Leckman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-09       Impact factor: 8.829

Review 7.  Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.

Authors:  Johnny Graham; David Coghill
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 8.  Tourette's syndrome: are stimulants safe?

Authors:  Roger Kurlan
Journal:  Curr Neurol Neurosci Rep       Date:  2003-07       Impact factor: 5.081

Review 9.  Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary.

Authors:  Mary M Robertson
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-02       Impact factor: 4.785

10.  Observations and ratings of tics in school settings.

Authors:  E E Nolan; K D Gadow; J Sverd
Journal:  J Abnorm Child Psychol       Date:  1994-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.